Involvement of CD14 and β2-Integrins in Activating Cells with Soluble and Particulate Lipopolysaccharides and Mannuronic Acid Polymers
Open Access
- 1 December 2000
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (12) , 6770-6776
- https://doi.org/10.1128/iai.68.12.6770-6776.2000
Abstract
Lipopolysaccharide (LPS) and related bacterial products can be recognized by host inflammatory cells in a particulate, bacterium-bound form, as well as in various soluble, released forms. In the present study we have compared the mechanisms used by LPS, detoxified LPS (DLPS), and mannuronic acid polymers (M-polymers), in solution or covalently linked to particles, in stimulating monocytes to tumor necrosis factor (TNF) production. The addition of recombinant LPS binding protein (LBP) and/or soluble CD14 (sCD14) enhanced the production of TNF from monocytes stimulated with soluble LPS, DLPS, or M-polymer, but did not affect the response to M-polymer or DLPS attached to particles. Treatment of monocytes with antibody to CD14, CD18, or CD11b showed that CD14, but not CR3 (CD11b/CD18), mediated monocyte TNF production in response to the soluble antigens. In contrast, anti-CD14, anti-CD11b and anti-CD18 monoclonal antibodies all inhibited the response to the particulate stimuli. On the other hand, B975, a synthetic analog ofRhodobacter capsulatuslipid A, completely abrogated the monocyte TNF response induced by LPS but did not affect the TNF induction by DLPS or M-polymer, either in soluble or particulate forms. These data demonstrate that the engagement of immune receptors by bacterial products such as LPS, DLPS, and M-polymer is dependent upon the presentation form of their constituent carbohydrates, and that factors such as aggregation state, acylation, carbohydrate chain length, and solid versus liquid phase of bacterial ligands influence the mechanisms used by cells in mediating proinflammatory responses.Keywords
This publication has 45 references indexed in Scilit:
- Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharideJournal of Clinical Investigation, 2000
- Human Monocyte Receptors Involved in Tumor Necrosis Factor Responses to Group B Streptococcal ProductsInfection and Immunity, 2000
- Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like ReceptorsScience, 1999
- Influence of CD 14, LBP and BPI in the Monocyte Response to LPS of Different Polysaccharide Chain LengthScandinavian Journal of Immunology, 1995
- Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.The Journal of Experimental Medicine, 1994
- The involvement of CD14 in stimulation of cytokine production by uronic acid polymersEuropean Journal of Immunology, 1993
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide.The Journal of Experimental Medicine, 1986
- Biochemical characterization of a soluble form of the 53‐kDa monocyte surface antigenEuropean Journal of Immunology, 1986
- The distribution of the CR3 receptor on human cells and tissue as revealed by a monoclonal antibodyClinical Immunology and Immunopathology, 1984